BY AURORA HEALTHCARE US CORP - Key Persons
Job Titles:
- Medical Officer, Aurora Healthcare / Chief Medical Officer, SunDoctor Aurora Medical Technology Ltd
Dr. Morse received his MD from The Harvard/MIT program in Health Sciences and Technology(HST). He completed his residency in OB/GYN at the Johns Hopkins Hospitals and a fellowship in Urogynecology at the Mayo Clinic. Prior to joining Aurora, Dr. Morse served as Chief of Urogynecology at Guangzhou Women and Children's Medical Center from 2016-2018 - one of few non-Chinese to serve in a clinical and administrative leadership role in a public hospital in China.
Job Titles:
- Clinical Vice President of Screening Programs, Aurora Healthcare Corp
- Medical Director Mercy Breast Center, Oklahoma City
Alan B. Hollingsworth, MD was the first breast-dedicated surgeon in Oklahoma where he was the Founding Medical Director of the OU Institute for Breast Health at his alma mater. There, he was the first Holder of the G. Rainey Williams Chair of Surgical Breast Oncology, and was a pioneer in risk assessment, genetic testing, and high-risk surveillance strategies. In 2000, he began a 20-year tenure as the Medical Director of the Mercy Hospital Breast Cancer Program in Oklahoma City where both his practice and research focused entirely on using breast MRI for screening and pre-operative tumor mapping. He currently serves on the Scientific Advisory Board of Aurora Healthcare US Corp, as well as the Clinical Vice President of Screening Programs.
In the 1980s, Dr. Hollingsworth was one of the earliest surgeons who transitioned to a breast-dedicated practice, who established one of the first multidisciplinary breast centers in the U.S. He was the First Holder of the G. Rainey Williams Chair of Surgical Breast Oncology at the University of Oklahoma.
Job Titles:
- Professor
- Professor / Chairman, China Rehabilitation Society of CACA
Professor Anli Shi has a lifetime dedication in China's healthcare. She led many key non-for-profit organizations such as:
Job Titles:
- Senior Fellow
- Chairman of Advisory Board, Aurora Healthcare / Chief Advisor, China Silk IValley Research Institute / Chairman of Hainan University International Advisory Board
- Senior Fellow Institute for Advanced Studies of Nanyang Technological University Singapore / Chief Advisor China Silk IValley Research Institute
- Senior Fellow of Singapore 's Nanyang Technological University
Feng's career crisscrosses academia, industry and government. Born and grew up in Singapore, Dr. Da Hsuan Feng received his theoretical physics Ph.D. from the University of Minnesota (1972). He joined Drexel University in 1976, and became M. Russell Wehr Chair Professor in 1990. While at Drexel, he also served for two years as NSF Program Director in Theoretical Physics, a visiting professor of the University of Copenhagen Niels Bohr Institute, the Institute which formulated quantum mechanics in the 20th century. From 1997-2000, he became Vice President of SAIC, aFortune 500 company where his portfolioranges from military to academia. In 2001, Feng assumed the Vice President for Research at the University of Texas at Dallas. From 2007-2017, Feng was the Senior Vice President of Cheng Kung University, Tsing Hua University in Taiwan, and Rector's Special Advisor and Director of Global Strategies of Macau University, respectively.
Currently, Feng is a Senior Fellow of Singapore's Nanyang Technological University's (NTU) Institute of Advanced Studies. Today, NTU is the fastest growing university on the global landscape. He is also the Chief Advisor of China Silk iValley Research Institute, the top 6 among the China's 600 Think-Tanks. He is now regarded as one of the experts in the implications of the belt and road initiative, and has been lecturing throughout Asia and North America.
Feng was bestowed the Fellow of the American Physical Society and is an honorary professor of fifteen Chinese universities and received the Bian-Zhong Award for Hubei Province 2009(年度湖北省编钟奖) and the "The Light of Civilization, the 2017 Chinese Cultural Exchange Award (文明之光·2017中国文化交流年度人物) award. He is a frequent editorial contributor to top Asian newspapers.
Feng consulted for Los Alamos, Oak Ridge and Brookhaven and UK's Daresbury Laboratories. He was an Advisor to the Chairman of the House Armed Services Committee. He was also an honorary Board of Trustee of Nanjing University, a former member of Shantou University Board of Trustees, an Academic Advisory Board member of Malaysia's Universiti Teknologi Petronas and Binus University in Indonesia. From 2005-2007, he was an independent board member of CellStar Board of Directors, a $1 Billion annual revenue global handset distribution company.
Job Titles:
- Chairman and Senior Partner of Martin
- Chairman and Senior Partner of Martin, Blanck & Associates
Dr. Blanck currently serves as chairman and senior partner of Martin, Blanck & Associates which is a leading healthcare consulting company.
Dr. Blanck received his Bachelor of Science from Juniata College in 1963, and a Doctorate of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine in 1967. He served for 32 years (1968-2000) in the US Army, culminating with his selection as the Army Surgeon General. Throughout his Army career, Dr. Blanck held a variety of administrative, academic and clinical positions, including: commander of Walter Reed Army Medical Center and North Atlantic Regional Medical Command; Director of Professional Services and chief of Medical Corps Affairs in the Office of the Surgeon General; Chief of the Department of Medicine at Brooke Army Medical Center; and service as a Battalion Surgeon during the Vietnam War.
Dr. Blanck joined the University of North Texas Health Science Center in 2000 after his retirement from the U.S. Army and served as president until 2006. He has also held a variety of academic appointments at USU, the University of Texas Health Science Center at San Antonio, Howard University, George Washington University and Georgetown University.
Dr. Blanck's military honors include Distinguished Service Medals, the Defense Superior Service Medal, the Legion of Merit, the Bronze Star Medal, Meritorious Service Medal and Army Commendation Medals.
In 2000, the American Medical Association honored Dr. Blanck with its highest award for government officials, the Dr. Nathan Davis Award. He is a master and past governor of the American College of Physicians. Additionally, he is a member of the American Medical Association, American Osteopathic Association and the Association of Military Surgeons of the United States. He serves as Chairman of the Education Commission on Foreign Medical Graduates.
Dr. Blanck also joined the boards of Delsite, Inc, Noblis, Inc, Trauma Cure, Inc and The Annapolis Center for Science-Based Public Policy.
Job Titles:
- Clinical Director
- Clinical Director, Oncology Department, Sichuan Provincial People 's Hospital
- Surgeon at Sichuan Provincial People 's Hospital
Jinping Liu Clinical Director, Oncology Department, Sichuan Provincial People's Hospital & Sichuan Academy of Medical Sciences. Professor, University of Electronic Science and Technology of China School of Medicine
Dr. Jinping Liu has been a surgeon at Sichuan Provincial People's Hospital ("SPPH") and Sichuan Academy of Medical Science since 1985 and a dedicated breast surgeon since 1992. He became Director of Breast Department in 2004 and Director of Oncology Department since 2013. Under Dr. Liu's leadership, SPPH established the first dedicated breast surgical specialty and implemented multidisciplinary in breast treatment
program in Sichuan. He closely followed the most cutting-edge trends in the world to advance better practice in the Department. He took initiatives to reform breast surgeries from traditional, extended or modified radical mastectomy to lumpectomy with confirmation from sentinel lymph node biopsy. Dr. Liu also champion in onco-plastic surgery, neoadjuvant chemotherapy, adjuvant chemotherapy, and biological targeted therapy.
Dr. Liu has also devoted to research aside from his clinical dedication. His research team established the first breast tumor biological sample tissue bank and built a thorough follow-up system post treatment. He participated in many multicenter clinical trials internationally and China's national new drug registration clinical trials. Dr. Liu actively served many other roles in nation-renowned and world-known institutions, such as American ASCO, ATLAS clinical trial collaboration group in UK, executive member at training expert committee of Chinese Medical Association and Breast Professional Committee of China Medical Education Association, to name a few. Dr. Liu finished his bachelor's degree from Luzhou Medical College (former of Southwest Medical University), and master's degree at Sichuan University Medical School. He has been a professor at School of Medicine, University of Electronic Science and Technology of China since 2005.
Job Titles:
- President of the AiXin Foundation
Dr. Yongkai Weng is President of the AiXin Foundation, a charity foundation established in the US. Dr. Weng graduated from Peking University in 1980, and received her Ph.D. in 1992 from Temple University in the US. She worked for the US FDA for 11 years in the research and regulatory field after completing her post-doctoral training at NCI in NIH.
Job Titles:
- Dean
- Dean of Tufts University School
- Dean, Tufts University School of Medicine
Harris A. Berman, MD is Dean of Tufts University School of Medicine, Professor of Medicine, and Professor of Public Health and Community Medicine. Prior to that, he was Vice Dean of the Medical School, and Dean of Public Health and Professional Degree Programs and Chair of the Department of Public Health and Family Medicine. Before coming to Tufts University he was a pioneer in the development of managed care in New England, and for 17 years, the CEO of the Tufts Health Plan.
Prior to joining Tufts Health Plan, Dr. Berman co-founded the Matthew Thornton Health Plan in Nashua, NH in 1971, one of the first HMOs in New England. He is currently a member of the Board of Directors of Tufts Medical Center, and its parent company, Wellforce, and until recently, of Tufts Health Plan.
Job Titles:
- Associate Professor
- Associate Professor, Department of Population Medicine, Harvard Medical School / President & Secretary General, U.S. - China Health Summit
As a population scientist, Professor Ma studies cancer etiology, prediction, prevention, and intervention. She served as PIs and co-PIs of hundreds of million dollar research funds from NIH and published over 200 peer review research papers in the top scientific journals. Dr. Ma had served as the co-PI of the Harvard School of Public Health (HSPH) Project "Advancing Breast Cancer Awareness and Prevention in China". She is recently invited by the Sichuan Provincial People's Hospital to serve as the funding director of their Center for Translational Medicine and Transformative Healthcare.
Dr. Ma is currently working on establishing a China Center at the Department of Populational Medicine (DPM), Harvard Medical School, with the mission of improving health care delivery and population health through innovative research and teaching. Since 2013, she also serves as the President and Secretary-General of the U.S.-China Health Summit, which is dedicated to the advancement of global health by promoting the exchange of knowledge, ideas, and experiences of healthcare leaders from the U.S., China, and other countries through high-level strategic dialogues, leadership development programs, and applied research.
Dr. Cheng joined the Company 2004 bringing over 20 years of extensive experience in product development and manufacturing in surgical, imaging systems and devices. From 1983 to 2003, Dr. Cheng worked for Cooper Vision Surgical Systems, American Hospital Supply Corporation, Baxter Edward Labs and Microptices Development Lab in divisions that developed and manufactured systems and devices used in ophthalmic, dental, heart and spine surgical operations.
He has M.S. degrees from UCLA and Cal State Polytech University and Ph.D. in Applied Physics and Engineering from UCLA.
Job Titles:
- President / St. Mary 's Hospital at Taitung
- President of St. Mary 's Hospital at Taitung, Taiwan
Ms. Chen is the President of St. Mary's Hospital - Taitung, Taiwan. She has long dedicated herself to courses including: advancing preventive medicine, health promotion, and social welfare. She has been also committed to the generalization of survivors support, greatly initiating the campaign of building up "Breast Cancer Survivors Support Groups" in Taiwan. In 2002, Ms. Chen facilitated the establishment of the "Association of Taiwanese Breast Cancer Patients", which becomes a significant service platform for breast cancer patients and survivors in
Job Titles:
- Owner, Hays Advising, LLC Executive - in - Residence, a.T. Kearney Consulting Former EVP, Walmart US, and Walmart China
Marybeth recently retired from a 25-year career in retail and consumer goods with companies including Walmart, Sam's Club, Lowe's Home Improvement, and Hanesbrands. Most recently, she was executive vice president of consumables and health & wellness for Walmart U.S. In that role, she managed a portfolio in excess of $85B USD, including such diverse categories as pharmacy (prescription and over-the-counter), health clinics and optical, baby, pet, personal care, beauty, and paper/cleaning.
From 2015 through 2017, she was chief merchandising, marketing, and supply chain officer for Walmart China, based in Shenzhen, Guangdong. In addition, Marybeth served on the Walmart Foundation global board of directors for six years.
Marybeth is a proud breast (8.5 yrs) and thyroid (1.5 yrs) cancer survivor. She spends time mentoring patients, is the top individual fundraiser for Susan G. Komen's Ozark Affiliate, and is a member of the board of directors of the Northwest Arkansas Cancer Challenge.
Marybeth earned both her BA and MBA from Wake Forest University in Winston-Salem, NC USA. She is the chairperson for the Board of Visitors for the Wake Forest School of Business.
Job Titles:
- Chairman, Sum Capital Partners
Job Titles:
- Co - Founder and President of MIC
- Co - Founder and President of MIC Group
Mr. Scott Lin is co-founder and president of MIC - Marketech International Corp. (public listed index TW:6196). MIC was established in 1988 to assist top international technology companies in semiconductor, optoelectronics and energy industries to safely and efficiently transfer technology and expand market in Asia. Under Scott's leadership, MIC grow rapidly from inception to achieve annual revenue approximate US$ 650 million and successfully listed its stock publicly since 2006. MIC is proud of its extensive world renowned customers list including AMAT, ASE, ASML, AUO, BOE, CSOT, INNOLUX, INTEL, HUA-WEI, MICRON, SMIC, TSMC, UMC, … to name a few.
Job Titles:
- CEO of Aurora Healthcare Corp
Olivia has served as CEO of Aurora Healthcare Corp ("Aurora"), a Massachusetts medical technology and global healthcare company for more than 10 years. Aurora was a spin-off from an MIT research project in the late 1990s when a group of MRI elite engineers committed to finding a solution using MRI technology for better detection of breast cancer which is the most prevalent disease among women. As the result, Aurora developed the only FDA cleared dedicated MRI system specifically designed for detecting and diagnosing breast cancer. Prior to leading Aurora, Olivia has nearly 20
years commercial and investment banking experience including being a high ranking Dedicated Authority Lender for Export-Import Bank of the United States and was appointed as one of the members in the White House Export Committee. She was also a co-founder of Pacific Republic Capital, a healthcare fund focused on investment in medical technology companies in the US and served as a board member for Accuray Inc., a NASDAQ listed radiosurgery company and a few other medical technology companies in the US. Olivia received her Master Degree in Economics from UCLA and Bachelor Degree from Taiwan National Chengchi University.
Olivia has also been active in serving as a board member of the following world-renowned
Job Titles:
- Professor of Physics, T.L.L. Temple Chair of Science at the University of Houston
Prof. Chu is a Chinese-American physicist specializing in superconductivity, magnetism, and dielectrics. He is currently Professor of Physics, T.L.L. Temple Chair of Science, and Founding Director and Chief Scientist of the Texas Center for Superconductivity at the University of Houston (TCSUH); Honorary Chancellor of the Taiwan Comprehensive University System; and President Emeritus and University Professor Emeritus of Hong Kong University of Science and Technology (HKUST).
In 1968, Prof. Chu received his Ph.D. degree at the University of California at San Diego in Physics. After two years of performing industrial research with Bell Laboratories at Murray Hill, New Jersey, Prof. Chu was appointed assistant professor of physics at Cleveland State University in 1970, and subsequently promoted to associate professor and professor of physics in 1973 and 1975, respectively. From 1979 till now, Prof. Chu served at University of Houston. He also has served as a consultant and visiting staff member at Bell Laboratories, Los Alamos Scientific Laboratory, the Marshall Space Flight Center, Argonne National Laboratory, and DuPont at various times.
Prof. Chu received numerous awards and honors for his outstanding works, including the National Medal of Science, the International Prize for New Materials, the Comstock Award, Texas Instruments' Founders' Prize, the World Cultural Council Medal of Scientific Merit, the New York Academy of Sciences' Physical and Mathematical Science Award, the Ettore Majorana - Erice - Science for Peace Prize, and the IEEE Council on Superconductivity Max Swerdlow Award.
Job Titles:
- Distinguished Research Professor
- Nobel Laureate Professor
Prof. Aaron Ciechanover is a distinguished research professor in the Technion - Israel Institute of Technology in Haifa. He received his M.Sc. (1971) and M.D. (1973) from the Hebrew University in Jerusalem. He then completed his national service (1973-1976) as a military physician, after which he continued his studies and obtained his doctorate degree in biological sciences in the Faculty of Medicine in the Technion (D.Sc. 1982). At that time, Prof. Aaron Ciechanover was a graduate student under Dr. Avram Hershko and in collaboration with Dr. Irwin A. Rose from the Fox Chase Cancer Center in Philadelphia, USA, when they discovered that covalent attachment of ubiquitin to a target protein signals it for degradation. After deciphering the mechanism of conjugation, they described the general proteolytic functions of the system and proposed a model according to which this modification serves as a recognition signal for a specific downstream protease. Along the years it has become clear that ubiquitin-mediated proteolysis plays major roles in numerous cellular processes, and aberrations in the system underlie the pathogenetic mechanisms of many diseases, among them certain malignancies and neurodegenerative disorders. Consequently, the system has become an important platform for drug development.
Job Titles:
- Global Director of Clinical Imaging
Rebecca Stough-Clinton, M.D., launched the first comprehensive breast MRI program in Oklahoma in 2003, facilitating the introduction of the Aurora breast dedicated MRI device at Mercy Health Center in Oklahoma City. Since then she has reviewed over 20,000 breast MRI examinations. With the Medical Director of the breast center, Alan B. Hollingsworth, M.D. she has co-authored numerous published articles regarding breast MRI. She has been a Castle Connelly Top Doctor in Oklahoma and in America as well as a US News & World Report, America's Top Doctors for Cancer. She was also named as an American Registry, America's Most Honored Professionals Top 1%. She has been an invited speaker nationally and internationally in Japan, Taiwan and China twice regarding breast MRI as well as image directed breast biopsies using Ultrasound and MRI.
Effective this year Dr. Becky retired from Mercy Breast Center to become the Global Director of Clinical Imaging for Aurora Healthcare, US Corp. Dr. Stough-Clinton is part of a team involved in the training and development of a comprehensive breast center in Asia which is to become a model for an Asian network.
Launching the first comprehensive breast MRI program in Oklahoma in 2003 she facilitated the introduction of Aurora MRI devices to Mercy Hospital Oklahoma delivering cutting edge care to the community. Dr. Stough has reviewed over 20,000 breast MRI examinations. Together with Dr. Alan Hollingsworth they have published numerous papers on breast MRI.
Dr. Stough is a graduate of the University of Oklahoma for undergraduate, medical school and radiology residency. She has practiced for over 4 decades in Oklahoma.
Job Titles:
- President
- President of Sichuan Provincial People 's Hospital
Shaoping Deng is President of Sichuan Provincial People's Hospital. He has been dedicated to the research of organ transplantation and diabetes for 27 years, with outstanding clinical and scientific achievements. He has published over 100 articles in international journals, including Natural Medicine, The Journal of Clinical Investigation, Diabetes, Transplantation Proceedings.
Job Titles:
- Certified Public Accountant
- Chief Financial Officer
- Executive Vice President
- CFO of Aurora Healthcare
Mr. James has served as Executive Vice President/Chief Financial Officer since 2003 and joined the Company as Chief Financial Officer in 1999. From 1997 to 1999, Mr. James was Chief Financial and Accounting Officer of Caprius, Inc, a NASDAQ listed company. From 1993 to 1997, he served as Chief Financial Officer of Medical Diagnostics, Inc. ("MDI") after joining that company as its Controller in 1988. Mr. James has served as CFO for both public and private companies.
Steven E. Harms, MD, FACR is recognized nationally in the area of magnetic resonance imaging (MRI). He was formerly on the faculty at the University of Arkansas for Medical Sciences (UAMS), Baylor University Medical Center in Dallas, and M. D. Anderson Cancer Institute. During his 14 years as director of MRI at Baylor, Dr. Harms and his research team developed numerous MRI applications including TMJ, knee, orbit and RODEO Breast MRI.
He is the former president of the Society of Magnetic Resonance in Medicine and received the AMA William Beaumont Award in 1995 (annually awarded to the outstanding physician in the nation under the age of 50). Harms was named "Komen Foundation Scientist of the Year" by Susan G. Komen for the Cure in 1998. He has authored over 116 scientific papers, 43 book chapters, and 11 patents. He was on the committee that wrote the current American Cancer Society breast cancer screening guidelines, which recommends breast MRI screening for high-risk patients. He was on the Board of Directors of the Society of Magnetic Resonance in Medicine (past-President) and the American Society of Breast Disease. He was served as a member and chairman of the Medical Devices Panel of the US Food and Drug Administration for over 17 years. He was awarded Fellow in the American College of Radiology and the Society of Breast Imaging. Harms practices at The Breast Center of Northwest Arkansas in Fayetteville, Arkansas a part of a larger multi-speciality practice, Medical Associates of Northwest Arkansas where he is a member of the executive committee and secretary and is Clinical Professor of Radiology at the University of Arkansas for Medical Sciences.
Job Titles:
- Chief Innovation Officer Kaohsiung Veterans General Hospital Originals & Enterprises
Tsung-Lung Yang received his Medical Doctor degree from School of Medicine, National Yang-Ming University, Taipei, Taiwan, in 1991 and completed his resident radiologist training at Kaohsiung Veterans General Hospital ( KSVGH) in 1997, then after one-year radiologist fellowship, became staff radiologist in 1998, and was promoted as the section chief in Teleradiology since 2007. He was the architect for building the enterprise-wide PACS (picture archiving and communication system) at KSVGH since
1998 and successfully transformed the traditional client-server PACS into a browser-server medical information platform in 2006 (solution name was dubbed H.E.L.P. representing Healthcare Enhancement and Leverage Platform) using private cloud solution. In 2011, he was the major contributor to help KSVGH to win her best government service award of the year and won the honor of best five IT medical institute of the year in Asia of FutureGov as well. In 2017, he also created a brand new system called AIS, an abbreviation for Application Information System, as a secure bridging service from HIS-PACS-RIS complex to reach patients to reduce medical illiteracy by providing Chinese-based infographic reports via an unique App on mobile devices, called 高榮乳篩 in Chinese and eMiqlat in English. His research interests include breast imaging, abdominal radiology, radiological informatics, radiomics, nursing informatics, electronic medical record, virtual reality for medicine and semantic web solutions for future medical platform services.
He was promoted as chief innovation officer to lead an unprecedented unit: KSVGH Originals and Enterprises to connect more people to drive innovation.
Job Titles:
- Chairman of Yihecheng Group Co., Ltd.
Mr. Chen is the founder and Chairman of Yihecheng Group Co., Ltd. (YHC) since its establishment in 1992 in Shandong, China. YHC has been engaged in production and sales of glass fiber series products in more than two decades. The company is the only high-tech private company produces series of glass and other related products which were heavily used as building materials for high-rise building and over 10,000 other high-tech products such as aircrafts and electronic devices. Thanks to China's fast growth economy, YHC steadily and rapidly grew to become a leading enterprise in the industry in China with 1,000 employees and enjoy market share over 60%.
In 2012, Mr. Chen invested and established Shandong Guyun Yangguang Rock Wool Group Co.,Ltd. (Sunshine RWG). Sunshine RWG was formed to significantly step up in manufacturing technology by pioneering in using imported cutting-edge equipment to adapt the most advanced global production process. This important investment and steps elevate YHC to the top position in the industry to produce efficiently the highest grad products with the largest manufacture capacity in China.
Job Titles:
- Director of Engineering and Service, Asia Division, Aurora Healthcar E
Mr. Pai has an M.S. degree in Automatic Control Engineering from Feng Chia University (Taiwan) and has more than 10 years of experience in MRI system Integration and service. Mr. Pai joined the Company in 2007 as an engineer and rose to the Director of Engineering for the Asia Division in 2009. During his tenure with the Company, Mr. Pai participated in R&D activities including developing the information system for remote diagnosis. He also led the System Service Division in Asia and was responsible for all the installations in Asia including Taiwan, China and Vietnam.
Job Titles:
- Professor and Dean, Peking Union School of Public Health ( PUSPH ) President, Chinese Aging Well Association / Founding Director, Harvard School of Public Health ( HSPH ) China Initiative
Dr. Yuanli Liu，with a Public Health and economics training background, has been serving as Professor of Health Policy and Management and Dean of School of Public Health at the Chinese Academy of Medical Sciences & Peking Union Medical College since 2013. From 1993 to 2013, Dr. Liu worked at Harvard School of Public Health in the area of global health policy and practice. In 2003, he served as one of the founding faculty members of a new doctoral major in health systems. From 2005 to 2015, he served as the founding director of Harvard China Health Initiative, responsible for organizing series of applied research studies, senior executives education program and high-level policy dialogues targeting at the major health policy and development issues facing China and the U.S.
Since returning back to his home country in 2013, Dr. Liu had been closely involved in China's healthcare reform and development initiatives as one of the leading policy advisers and organizers of top Think-Tank and social organizations. He currently serves as a member of the State Council Healthcare Reform Expert Committee, President of the Chinese Aging Well Association, Vice Chairman of the National Commission on Health Promotion and Education, a member of the National Commission for Development of Traditional Chinese Medicine, the National Commission for drafting the Essential Healthcare and Health Promotion Law. In 2017, Dr. Liu was named one of the top 50 most influential people in China with an overseas education and working background. He also has consulted for many international organizations including WHO, WB and Fortune 500 companies.